InfiniteMD Revenue and Competitors
Estimated Revenue & Valuation
- InfiniteMD's estimated annual revenue is currently $7.5M per year.
- InfiniteMD's estimated revenue per employee is $3,750,000
Employee Data
- InfiniteMD has 2 Employees.
- InfiniteMD grew their employee count by 0% last year.
InfiniteMD's People
Name | Title | Email/Phone |
---|
InfiniteMD Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.5M | 102 | 28% | N/A | N/A |
#2 | N/A | 5 | 0% | N/A | N/A |
#3 | N/A | 53 | 56% | N/A | N/A |
#4 | N/A | 7 | 17% | N/A | N/A |
#5 | $1.7M | 13 | -13% | N/A | N/A |
#6 | N/A | 16 | 23% | N/A | N/A |
#7 | $1.7M | 10 | -23% | N/A | N/A |
#8 | N/A | 10 | 11% | N/A | N/A |
#9 | $7.5M | 77 | 4% | N/A | N/A |
#10 | N/A | 34 | 31% | N/A | N/A |
What Is InfiniteMD?
InfiniteMD is joining ConsumerMedical! Together, we are setting a new standard for expert medical guidance. InfiniteMD is virtual expert opinion leader that provides consumers from around the world direct access to the best physicians in the United States via remote video and written consultations using its proprietary platform. Headquartered in Boston, Massachusetts, InfiniteMD works with physicians from institutions like Harvard Medical School-affiliated hospitals and other clinical centers of excellence that rank within the Top 20 Hospitals, per U.S. News and World Report. A cornerstone of InfiniteMD’s service is the translation and summarization of medical records in any language for our physician network, as well as providing medically trained interpreters during live video consultations.
keywords:N/AN/A
Total Funding
2
Number of Employees
$7.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.2M | 2 | -33% | N/A |
#2 | $0M | 2 | 0% | $1M |
#3 | $0.2M | 2 | 0% | N/A |
#4 | $0.3M | 2 | -71% | N/A |
#5 | $0.1M | 2 | -33% | N/A |